Alpha-Melanocyte Stimulating Hormone as Topical Anti-Inflammatory Agent for the Treatment of Allergic Contact Dermatitis and Eczema
- Detailed Technology Description
- The invention provides a pharmaceutical formulation for topical administration comprising a-MSH or analogues of a-MSH to treat inflammatory skin disorders, particularly eczematous inflammatory disorders and allergic contact dermatitis.
- *Abstract
-
A method is presented for treating an inflammatory skin disorder in a human comprising: topically applying to the disorder in a human comprising alpha-melanocyte stimulating hormone (aMSH) or an aMSH analog in an amount effective to reduce skin inflammation in the human.
- Country/Region
- USA
For more information, please click Here

